This grant funds research to understand cardiovascular disease in type 1 diabetes by supporting collaborative, multi-omics studies through the CARE-T1D consortium.
Funder: National Institutes of Health
Due Dates: March 10, 2027
Funding Amounts: Up to $500,000 per award; estimated total program funding is $6,000,000; approximately 8 awards expected.
Summary: Supports collaborative research to advance understanding of cardiovascular disease mechanisms and complications in individuals with type 1 diabetes.
This funding opportunity supports the continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) Consortium. The program aims to promote interdisciplinary and collaborative research into the mechanisms underlying cardiovascular disease (CVD) in people with type 1 diabetes (T1D). Cardiovascular complications are the leading cause of death among individuals with T1D, yet the biological pathways and effective therapies remain poorly understood. This initiative seeks to address these gaps by supporting research that enhances understanding of atherosclerosis, cardiomyopathy, endothelial dysfunction, and cardiac autonomic neuropathy in T1D, as well as the differences between CVD in T1D and other populations. The program is part of the Special Diabetes Program, which funds research on prevention, treatment, and cure of T1D and its complications.